Renaissance Capital logo

NTHI News

Brain cancer biotech NeOnc Technologies withdraws $75 million IPO

NeOnc Technologies Holdings logo

NeOnc Technologies Holdings, a Phase 2 biotech developing intranasal and oral therapies for brain cancer, withdrew its plans for an initial public offering on Wednesday. It had filed to raise $75 million by offering 6 million shares at a price range of $11.25 to...read more

US IPO Week Ahead: IPO market starts with a quiet week as potential launches loom

PACS

Updated Monday, 4/1. The April IPO market is starting off with a fairly quiet calendar, with one large issuer scheduled for the week ahead. That could change, as several issuers are teed up for potential launches. Potential calendar additions include...read more

US IPO Weekly Recap: 7 new filers join the pipeline as Reddit and Auna launch

NTHI

No IPOs debuted this past, as two companies previously scheduled to list (NTHI and RAN) kicked the can down the road. Seven IPOs and one SPAC submitted initial filings this week. Meanwhile, social media platform Reddit (RDDT) launched its...read more

US IPO Week Ahead: Oncology biotech and drone maker set to debut

NTHI

Two listings are currently scheduled for the week ahead, although one is excluded from our IPO stats. Other issuers may join the calendar throughout the week. Phase 2 brain cancer biotech NeOnc Technologies (NTHI) plans to raise $75 million...read more